BioPharmaFocus on the pharmaceutical and biotech industry
- Alnylam Overview
Barry Greene, President of Alnylam, joined the company in 2003 and has more than 25 years of experience in healthcare, pharmaceutical, and biotechnology industries.
- Interecept Pharma: Focused on Non-Viral Liver Diseases
Gail Cawkwell, MD, PhD, Senior Vice President, Medical Affairs at Intercept, provides an overview of the company.
- Corbus Pharmaceuticals Corporate Overview
Yuval Cohen, PhD, CEO of Corbus Pharmaceuticals discusses his company’s growth over the past few years and provided an overview of Lenabasum, a novel, oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes.
- Baebies: Newborn Screening Platforms
Richard West, Founder and CEO of Baebies, a newborn testing diagnostic company. In this video, Mr West discusses the company’s two main platforms.
- ArQule’s Focus on Rare Diseases
Brian Schwartz, Chief Medical Officer of ArQule, discusses his company and it’s focus on disease management.
- Participating at the BIO Convention
Yuval Cohen, PhD, CEO of Corbus Pharmaceuticals discusses the importance of his company’s support for the BIO International Convention.
- The Current Biotech Business Cycle
Chris Garabedian discusses the current biotech boom and historical norms for this industry. The biotechnology sector has always been one of the most volatile of all sectors, and has had a large run-up in value over the last five years.
- ProQR: The Importance of Working With Rare Disease Advocacy Groups
Daniel de Boer, Founder and CEO of ProQR, discusses his company’s working relationships with various rare disease advocacy groups.
- Alnylam’s Clinical Focus
Barry Greene, President of Alnylam, provides an overview of his company and the science of RNA interference (RNAi).
- The Success of the Orphan Drug Act
Mr. Robert (Bob) E. Ward, Chairman of the Board and Chief Executive Officer of Eloxx Pharmaceuticals discusses the success of the Orphan Drug Act (ODA).